New Oral Agent Approved for Relapsing Multiple Sclerosis

(MedPage Today) -- The FDA approved oral ponesimod (Ponvory) to treat relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, drugmaker Janssen announced...